Gambaran Umum
Organon & Co., headquartered in Jersey City, New Jersey, United States, operates predominantly in the pharmaceutical industry with a primary focus on women's health. Established as a spin-off from Merck & Co. in 2021, Organon is committed to improving the health of women throughout their lives. The company's portfolio includes a diversified mix of off-patent branded and generic medicines, along with reproductive health products. Furthermore, Organon actively pursues strategic acquisitions and collaborations to bolster its offerings in global healthcare markets. Key projects include advancing contraceptive technologies and treatments for diseases that predominantly affect women, demonstrating Organon’s targeted Dedication to addressing unmet medical needs in female healthcare.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Organon & Co. per 2025 Jun 30 adalah 6,281.00 MM.
- Nilai operating income untuk Organon & Co. per 2025 Jun 30 adalah 1,358.00 MM.
- Nilai net income untuk Organon & Co. per 2025 Jun 30 adalah 700.00 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 6,281.00 | 1,358.00 | 700.00 |
| 2025-03-31 | 6,294.00 | 1,408.00 | 750.00 |
| 2024-12-31 | 6,403.00 | 1,488.00 | 864.00 |
| 2024-09-30 | 6,409.00 | 1,504.00 | 1,301.00 |
| 2024-06-30 | 6,346.00 | 1,426.00 | 1,000.00 |
| 2024-03-31 | 6,347.00 | 1,429.00 | 1,047.00 |
| 2023-12-31 | 6,263.00 | 1,409.00 | 1,023.00 |
| 2023-09-30 | 6,150.00 | 1,305.00 | 585.00 |
| 2023-06-30 | 6,168.00 | 1,492.00 | 754.00 |
| 2023-03-31 | 6,145.00 | 1,571.00 | 746.00 |
| 2022-12-31 | 6,174.00 | 1,712.00 | 917.00 |
| 2022-09-30 | 6,292.00 | 1,844.00 | 1,011.00 |
| 2022-06-30 | 6,355.00 | 1,942.00 | 1,107.00 |
| 2022-03-31 | 6,365.00 | 1,994.00 | 1,300.00 |
| 2021-12-31 | 6,304.00 | 1,921.00 | 1,351.00 |
| 2021-09-30 | 6,314.00 | 2,036.00 | 1,517.00 |
| 2021-06-30 | 6,327.00 | 2,222.00 | 1,741.00 |
| 2021-03-31 | 6,258.00 | 2,433.00 | 1,856.00 |
| 2020-12-31 | 6,532.00 | 2,847.00 | 2,160.00 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | 3.36 | 3.33 |
| 2024-09-30 | 5.07 | 5.04 |
| 2024-06-30 | 3.91 | 3.88 |
| 2024-03-31 | 4.10 | 4.08 |
| 2023-12-31 | 4.01 | 3.99 |
| 2023-09-30 | 2.29 | 2.28 |
| 2023-06-30 | 2.96 | 2.95 |
| 2023-03-31 | 2.93 | 2.92 |
| 2022-12-31 | 3.61 | 3.59 |
| 2022-09-30 | 3.98 | 3.96 |
| 2022-06-30 | 4.36 | 4.34 |
| 2022-03-31 | 5.13 | 5.10 |
| 2021-12-31 | 5.33 | 5.31 |
| 2021-09-30 | 5.98 | 5.97 |
| 2021-06-30 | 6.87 | 6.86 |
| 2021-03-31 | 7.32 | 7.32 |
| 2020-12-31 | 8.52 | 8.52 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Organon & Co. per 2025 Jun 30 adalah 826.00 MM.
- Nilai cash from investing activities untuk Organon & Co. per 2025 Jun 30 adalah -581.00 MM.
- Nilai kas dari aktivitas pendanaan untuk Organon & Co. per 2025 Jun 30 adalah -458.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | 826.00 | -581.00 | -458.00 |
| 2025-03-31 | 938.00 | -589.00 | -369.00 |
| 2024-12-31 | 939.00 | -513.00 | -368.00 |
| 2024-09-30 | 946.00 | -298.00 | -363.00 |
| 2024-06-30 | 1,066.00 | -278.00 | -363.00 |
| 2024-03-31 | 761.00 | -302.00 | -317.00 |
| 2023-12-31 | 799.00 | -260.00 | -569.00 |
| 2023-09-30 | 669.00 | -240.00 | -574.00 |
| 2023-06-30 | 725.00 | -398.00 | -573.00 |
| 2023-03-31 | 849.00 | -411.00 | -668.00 |
| 2022-12-31 | 858.00 | -420.00 | -433.00 |
| 2022-09-30 | 638.00 | -492.00 | -538.00 |
| 2022-06-30 | 689.00 | -340.00 | -479.00 |
| 2022-03-31 | 1,077.00 | -506.00 | -63.00 |
| 2021-12-31 | 2,458.00 | -481.00 | -1,333.00 |
| 2021-09-30 | 2,841.00 | -466.00 | -1,823.00 |
| 2021-06-30 | 2,761.00 | -455.00 | -2,108.00 |
| 2021-03-31 | 3,025.00 | -247.00 | -2,918.00 |
| 2020-12-31 | 2,187.00 | -258.00 | -2,175.00 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | |||
| 2021-03-31 | |||
| 2020-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | ||
| 2021-09-30 | ||
| 2021-06-30 | ||
| 2021-03-31 | ||
| 2020-12-31 |
Efektivitas Manajemen
- roe untuk Organon & Co. pada 2025 Jun 30 adalah 0.00.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2025-06-30 | 0.00 | ||||
| 2025-03-31 | 0.00 | ||||
| 2024-12-31 | 0.00 | ||||
| 2024-09-30 | 0.00 | ||||
| 2024-06-30 | 0.00 | ||||
| 2024-03-31 | 0.00 | ||||
| 2023-12-31 | 0.00 | ||||
| 2023-09-30 | 0.00 | ||||
| 2023-06-30 | 0.00 | ||||
| 2023-03-31 | 0.00 | ||||
| 2022-12-31 | 0.00 | ||||
| 2022-09-30 | 0.00 | ||||
| 2022-06-30 | 0.00 | ||||
| 2022-03-31 | 0.00 | ||||
| 2021-12-31 | 0.00 | ||||
| 2021-09-30 | 0.00 | ||||
| 2021-06-30 | 0.00 | ||||
| 2021-03-31 | 0.00 | ||||
| 2020-12-31 | 0.20 | 0.31 | 0.31 | -0.04 | 0.32 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | |||
| 2021-03-31 | |||
| 2020-12-31 | 0.68 | 0.33 | 0.46 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) | 1821825 |
Grupong Pang-industriya
| SIC 2834 - Pharmaceutical Preparations |
